Making safe sense of an anti-sense!
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 35106512.
- Also identified by DOI 10.1016/j.xcrm.2021.100503 and PMC identifier 8784792.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bepiroversen has been developed and trialed for the cure of HBV. Yuen et al.<sup>1</sup> report on the safety and antiviral efficacy of this agent. We "spotlight" key findings of this study and its impact for future clinical trial design.
Medical subject headings
- Antiviral Agents